Market Place
Sourcing Support
Avenacy Launches Palonosetron Hydrochloride Injection In US Market
22 Jul 2024 //
BUSINESSWIRE
Helsinn Group launches Akynzeo injection in US market
26 Jun 2024 //
PHARMABIZ
Helsinn & Chugai sign a partnership agreement renewal to commercialize AKYNZEO
12 Jun 2024 //
GLOBENEWSWIRE
Helsinn announces publication of data evaluating impact of AKYNZEO
12 Jun 2023 //
GLOBENEWSWIRE
Glenmark introduces medication to prevent chemotherapy-induced nausea
23 Jan 2023 //
ECONOMIC TIMES
Farma Mondo Group & Helsinn sign exclusive partnership to commercialize AKYNZEO
28 Nov 2022 //
GLOBENEWSWIRE
Baxter Healthcare `s Generic Palonosetron HCL Receives Approval In US
16 Nov 2021 //
FDA
Emcure Pharms` Generic Palonosetron Hydrochloride Receives Approval In US
29 Jun 2021 //
FDA
Accord Hlthcare`s Generic Palonosetron Hydrochloride Receives Approval In US
23 Mar 2021 //
FDA
Helsinn Group and Italfarmaco announces oral presentation of NEPA data
18 Sep 2020 //
PRESS RELEASE
Ingenus Pharms`s Generic Palonosetron Hydrochloride Receives Approval in US
28 May 2020 //
FDA
Five meds recommended in final 2019 CHMP meeting
16 Dec 2019 //
PHARMA TIMES
Aloxi (palonosetron hydrochloride): Helsinn Healthcare vs. Baxter Healthcare
24 Nov 2018 //
PATENT LITIGATION
AmerisourceBergen to pay $625 million in U.S. civil fraud settlement
02 Oct 2018 //
REUTERS
Hospira`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Cipla Ltd`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Sagent Pharms`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Qilu Pharma`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Mylan Institl Generic Palonosetron Hydrochloride Receives Approval in the US
21 Sep 2018 //
FDA
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection
15 Sep 2018 //
EDQM
Glenmark launches Helsinn`s Akynzeo in India
11 Jul 2018 //
BIOSPECTRUM
Glenmark expands its oncology franchise in India with launch of Akynzeo
11 Jul 2018 //
ECONOMIC TIMES
Glenmark launches FDC drug Akynzeo for chemotherapy-induced nausea and vomiting
10 Jul 2018 //
PHARMABIZ
Helsinn (U.S.) becomes the exclusive distributor of ALOXI® (palonosetron HCI)
29 Jun 2018 //
GLOBENEWSWIRE
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI®
28 Jun 2018 //
GLOBENEWSWIRE
Sagent Pharms Generic Palonosetron HCL Receives Tentative Approval In US
22 May 2018 //
FDA
Sagent Pharms Generic Palonosetron Hydrochloride Receives Approval In US
22 May 2018 //
FDA
Sagent Pharm’s Generic Palonosetron Hydrochloride Receives Approval In US
24 Apr 2018 //
FDA
Glenmark gets license to market Akynzeo in India
04 Apr 2018 //
THEPHARMALETTER
Dr Reddy`s launches generic nausea drug in US
27 Mar 2018 //
ECONOMIC TIMES
Teva Announces the Launch of a Generic Version of ALOXI® in the United States
23 Mar 2018 //
BUSINESSWIRE
Mundipharma acquires Australia`s Tolmar; adds Eligard to its portfolio
20 Feb 2018 //
BIOSPECTRUM
Lenalidomide approved and 3 more treatments for cancer
27 Dec 2017 //
ANVISA
Patent battle for Aloxi in the US
04 May 2017 //
MANUFACTIRING
DRL gets unfavourable patent ruling in US court
17 Feb 2017 //
FINANCIAL EXPRESS
Mundipharma expands oncology portfolio
16 Feb 2017 //
BIOSPECTRUM
Teva`s Generic Palonosetron Hcl Injection Approved In US
06 Oct 2016 //
Optimization of melt in mouth tablets of palonosetron HCl
03 Oct 2016 //
PHARMA-EXCIPIENTS
Optimization of Melt in Mouth Tablets of Palonosetron
03 Sep 2016 //
PHARMA-EXCIPIENTS
EXELA PHARMA SCS LLC Palonosetron Hydrochloride Approved By FDA
22 Aug 2016 //
FDA
Sandoz`s Generic Bimatoprost approved in US for Glaucoma
19 Apr 2016 //
FDA
Seven new therapies jump towards EU approval
04 Apr 2016 //
PHARMATIMES
Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise
18 Mar 2016 //
PR NEWS WIRE
Six new therapies approved for NHS Scotland
12 Jan 2016 //
PHARMATIMES
New York man convicted of selling counterfeit and illegal drugs in U.S.
23 Nov 2015 //
FIERCE PHARMA MANUFACTURING
Helsinn Group and Eisai Inc. Announce Inclusion of AKYNZEO in ASCO
13 Nov 2015 //
PR NEWS WIRE
Palonosetron API Cost Estimate
23 Oct 2015 //
Chugai Pharma launches netupitant-palonosetron fixed dose combo in UK
10 Sep 2015 //
PHARMABIZ
